Optimization of the experimental parameters in the determination of lamotrigine by adsorptive stripping voltammetry

Determination of lamotrigine by fluorescence quenching of N-doped graphene quantum dots after its solid-phase extraction using magnetic graphene oxide

A sensitive fluorescent nanoprobe is reported for the determination of lamotrigine after its preconcentration by magnetic graphene oxide nanocomposite. The fluorescent nanoprobe is based on the quenching effect of lamotrigine on the nitrogen graphene quantum dots fluorescence at 440 nm, through strong hydrogen bonding. Under optimum conditions, the quenching fluorescent intensity of nitrogen graphene quantum dots shows linearity with the lamotrigine concentration in the range of 2.0-45.0 µg L^-1, limits of detection (LOD), and quantification of 0.39 and 1.28 µg L^-1 respectively. The parameters affecting the extraction and determination of lamotrigine were optimized via the central composite design (CCD) and one at the time method, respectively. The developed method was successfully employed for the extraction and quantification of lamotrigine in biological samples.

Recent advances in electroanalytical methods for the therapeutic monitoring of antiepileptic drugs: A comprehensive review

Frequency of seizures is often managed by a wide group of antiepileptic drugs. Regarding the pharmacokinetic variability, narrow targeted range, and difficulty of detecting signs of toxicity based on laboratory responses, therapeutic monitoring of antiepileptic drugs can play a pivotal role in optimizing the drug dosage. Electrochemical sensors and biosensors can facilitate analysis of these drugs due to their unique advantages such as fast analysis, sensitivity, selectivity, and low cost. This review article, for the first time, describes the recent advances in electrochemical sensors and biosensors developed for the analysis of antiepileptic drugs. General electrochemical measuring techniques and types of applied electrode substrates were described first. To simplify the work, various chemical and biological modifiers applied to improve the sensitivity and selectivity of the sensors were classified and explained briefly. Finally, the future prospective on the development of electrochemical platforms in the quantification of antiepileptic drugs will be presented.

Application of magnetic lamotrigine-imprinted polymer nanoparticles as an electrochemical sensor for trace determination of lamotrigine in biological samples

A magnet contain carbon paste electrode based on for magnetic molecularly imprinted polymer nanoparticles have been synthesized for the preconcentration and selective trace determination of lamotrigine (LTG) in urine and plasma samples.

Highly sensitive voltammetric determination of lamotrigine at highly oriented pyrolytic graphite electrode

The electrochemical behavior of lamotrigine (LMT) at the pyrolytic graphite electrode (PGE) is investigated in detail by the means of cyclic voltammetry. During the electrochemical reduction of LMT, an irreversible cathodic peak appeared. Cyclic voltammetric studies indicated that the reduction process has an irreversible and adsorption-like behavior. The observed reduction peak is attributed to a two-electron process referring to the reduction of azo group. The electrode showed an excellent electrochemical activity toward the electro-reduction of LMT, leading to a significant improvement in sensitivity as compared to the glassy carbon electrode. The results of electrochemical impedance spectroscopy and cyclic voltammetry showed that edge-plane pyrolytic graphite electrode has excellent electrochemical response properties toward LMTs with respect to glassy carbon electrode modified with carbon nanotubes. High sensitivity, low detection limit and very good repeatability together with excellent recovery make the electrode as a powerful devise for accurate determination of LMT in pharmaceutical and biological samples.

Validated spectrofluorimetric method for the determination of lamotrigine in tablets and human plasma through derivatization with o-phthalaldehyde

A sensitive, simple and selective spectrofluorimetric method was developed for the determination of Lamotrigine (LMT) in pharmaceutical formulations and biological fluids. The method is based on reaction of LMT with o-phthalaldehyde in presence of 2-mercaptoethanol in borate buffer of pH 9.8 to yield a highly fluorescent derivative that is measured at 448 nm after excitation at 337 nm. The different experimental parameters affecting the development and stability of the reaction product were carefully studied and optimized. The fluorescence-concentration plot was rectilinear over the range of 0.1-1.0 microg ml(-1) with lower limit of detection (LOD) 0.02 microg ml(-1) and limit of quantification (LOQ) 0.06 microg ml(-1) respectively. The proposed method was successfully applied to the the analysis of commercial tablets. Statistical comparison of the results obtained by the proposed and reference method revealed no significant difference in the performance of the two methods regarding the accuracy and precision respectively. The proposed method was further extended to the in-vitro and in-vivo determination of the drug in spiked and real human plasma. The mean percentage recoveries in spiked and real human plasma (n = 3) were 95.78 +/- 1.37 and 90.93 +/- 2.34 respectively. Interference arising from co-administered drugs was also studied. A proposal for the reaction pathway with o-phthalaldehyde was postulated.

Determination of Lamotrigine in Pharmaceutical Preparations by Adsorptive Stripping Voltammetry Using Screen Printed Electrodes

This paper describes a procedure that has been optimized for the determination of lamotrigine by Differential Pulse Adsorptive Stripping Voltammetry (DPAdSV) using carbon screen-printed electrodes (CSPE) and mercury coated carbon screen-printed electrodes. Selection of the experimental parameters was made using experimental design methodology. The detection limit found was 5.0 x 10^-6 M and 2.0 x 10^-6 M for the non modified and Hg modified CSPE, respectively. In terms of reproducibility, the precision of the above mentioned methods was calculated in %RSD values at 9.83% for CSPE and 2.73% for Hg-CSPE. The Hg-coated CSPEs developed in this work were successfully applied in the determination of lamotrigine in pharmaceutical preparations.

Determination of oxcarbazepine by Square Wave Adsorptive Stripping Voltammetry in pharmaceutical preparations

A procedure for the determination of oxcarbazepine (OXC) by Square Wave Adsorptive Stripping Voltammetry (SWAdSV) has been optimized. Selection of the experimental parameters was made using experimental design methodology. The detection limit was 1.74 x 10(-7) mol dm(-3). This method was used to determine oxcarbazepine in pharmaceutical preparations.

Voltammetric Determination of Copper and Lead in Gasoline Using Sample Preparation as Microemulsions

A voltammetric method for the determination of Cu(II) and Pb(II) in gasoline using sample preparation as three-component solutions (gasoline:propan-1-ol:water, 25:60:15 v/v/v) is proposed. HNO(3) was employed as a supporting electrolyte and to allow the use of aqueous inorganic standards for calibration, even if the analyte species originally in gasoline is present as a metallo-organic form. A square-wave anodic sequential determination was used by measuring the stripping current of Cu(II) (at +104 mV) using a glassy carbon electrode (GCE) and, in a second run, measuring the Pb(II) stripping current (at -470 mV) using a bismuth-film deposited on the surface of the GCE. The method allowed the quantification of 1.7 x 10(-9) mol L(-1) of Cu and 1.4 x 10(-10) mol L(-1) of Pb employing a 1500-s accumulation time. Recovery tests using analyte spiked three-component solutions prepared with commercial gasoline samples enabled recoveries of Cu and Pb from 97 +/- 8 to 102 +/- 5%.